Interact to see
Advertisement
Advertisement
VIGAX vs VRLCX
VIGAX vs VRLCX Comparison
Open Charts VIGAX vs VRLCX
Vanguard Growth Index Admiral
Price$237.81
Change-$0.80 (-0.34%)
VolumeN/A
Net Assets324.3B
Voya Large Cap Growth Port R6
Price$17.97
Change-$0.07 (-0.39%)
VolumeN/A
Net Assets2.37B
VIGAX vs VRLCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
VIGAX vs. VRLCX commentary
Aug 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VIGAX is a Buy and VRLCX is a Buy.
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 324B vs. VRLCX (2.37B). VIGAX pays higher dividends than VRLCX: VIGAX (0.43) vs VRLCX (0.00). VIGAX was incepted earlier than VRLCX: VIGAX (25 years) vs VRLCX (10 years). VRLCX (0.68) is less costly to investors than VIGAX (0.05). VRLCX is a more actively managed with annual turnover of: 42.00 vs. VIGAX (11.00). VRLCX has a lower initial minimum investment than VIGAX: VRLCX (0) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 24.02 vs. VRLCX (8.65). VIGAX return over 5 years is better than : 107.21 vs. VRLCX (-11.43).
| VIGAX | VRLCX | VIGAX / VRLCX | |
| Total Expense Ratio | 0.05 | 0.67 | 7% |
| Annual Report Gross Expense Ratio | 0.05 | 0.68 | 7% |
| Fund Existence | 25 years | 10 years | - |
| Gain YTD | 12.589 | -2.284 | -551% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 3000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 324B | 2.37B | 13,654% |
| Annual Yield % from dividends | 0.43 | 0.00 | - |
| Returns for 1 year | 24.02 | 8.65 | 278% |
| Returns for 3 years | 73.68 | 52.16 | 141% |
| Returns for 5 years | 107.21 | -11.43 | -938% |
| Returns for 10 years | 321.60 | N/A | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SBHIX | 22.90 | 0.18 | +0.79% |
| Saratoga Health & Biotechnology I | |||
| FCUIX | 20.41 | 0.03 | +0.15% |
| NYLI PineStone U.S. Equity Class I | |||
| ASERX | 120.94 | -0.40 | -0.33% |
| American Century Select R | |||
| MUETX | 38.86 | -0.14 | -0.36% |
| MFS Blended Research Core Equity R3 | |||
| FISGX | 41.43 | -0.15 | -0.36% |
| Nuveen Small/Mid Cap Growth Opp I | |||